Amidon GL - Search Results

1

Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract.

Yu A, Baker JR, Fioritto AF, Wang Y, Luo R, Li S, Wen B, Bly M, Tsume Y, Koenigsknecht MJ, Zhang X, Lionberger R, Amidon GL, Hasler WL, Sun D. Yu A, et al. Among authors: amidon gl. Mol Pharm. 2017 Feb 6;14(2):345-358. doi: 10.1021/acs.molpharmaceut.6b00641. Epub 2016 Dec 23. Mol Pharm. 2017. PMID: 28009518

2

Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.

Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee KD, Amidon GL. Sun D, et al. Among authors: amidon gl. Pharm Res. 2002 Oct;19(10):1400-16. doi: 10.1023/a:1020483911355. Pharm Res. 2002. PMID: 12425456 Free article.

3

Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters.

Landowski CP, Sun D, Foster DR, Menon SS, Barnett JL, Welage LS, Ramachandran C, Amidon GL. Landowski CP, et al. Among authors: amidon gl. J Pharmacol Exp Ther. 2003 Aug;306(2):778-86. doi: 10.1124/jpet.103.051011. Epub 2003 May 15. J Pharmacol Exp Ther. 2003. PMID: 12750437 Clinical Trial.

4

Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum.

Shin HC, Landowski CP, Sun D, Vig BS, Kim I, Mittal S, Lane M, Rosania G, Drach JC, Amidon GL. Shin HC, et al. Among authors: amidon gl. Biochem Biophys Res Commun. 2003 Aug 1;307(3):696-703. doi: 10.1016/s0006-291x(03)01259-2. Biochem Biophys Res Commun. 2003. PMID: 12893280

5

Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs.

Yu LX, Carlin AS, Amidon GL, Hussain AS. Yu LX, et al. Among authors: amidon gl. Int J Pharm. 2004 Feb 11;270(1-2):221-7. doi: 10.1016/j.ijpharm.2003.10.016. Int J Pharm. 2004. PMID: 14726137

6

In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.

Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL. Sun D, et al. Among authors: amidon gl. Curr Opin Drug Discov Devel. 2004 Jan;7(1):75-85. Curr Opin Drug Discov Devel. 2004. PMID: 14982151 Review.

7

Transporter and ion channel gene expression after Caco-2 cell differentiation using 2 different microarray technologies.

Landowski CP, Anderle P, Sun D, Sadee W, Amidon GL. Landowski CP, et al. Among authors: amidon gl. AAPS J. 2004 Sep 7;6(3):e21. doi: 10.1208/aapsj060321. AAPS J. 2004. PMID: 15760106 Free PMC article.

8

Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.

Mittal S, Song X, Vig BS, Landowski CP, Kim I, Hilfinger JM, Amidon GL. Mittal S, et al. Among authors: amidon gl. Mol Pharm. 2005 Jan-Feb;2(1):37-46. doi: 10.1021/mp049922p. Mol Pharm. 2005. PMID: 15804176

9

Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.

Song X, Lorenzi PL, Landowski CP, Vig BS, Hilfinger JM, Amidon GL. Song X, et al. Among authors: amidon gl. Mol Pharm. 2005 Mar-Apr;2(2):157-67. doi: 10.1021/mp049888e. Mol Pharm. 2005. PMID: 15804190

10

Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.

Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. Kasim NA, et al. Among authors: amidon gl. Mol Pharm. 2004 Jan 12;1(1):85-96. doi: 10.1021/mp034006h. Mol Pharm. 2004. PMID: 15832504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page